Evidence map›Paper›PMID 21335042›Full record

ArticlePeptides2011

The natriuretic mechanism of Gamma-Melanocyte-Stimulating Hormone.

Paru P Kathpalia, Carol Charlton, Madhumitha Rajagopal, Alan C Pao

Open access · greenAbstract read
In one paragraph

Article in Peptides, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paru P KathpaliaDepartment of Medicine, Division of Nephrology, Stanford University, Stanford, CA 94305, United States.
Carol Charlton
Madhumitha Rajagopal
Alan C Pao
Stanford University · US

Funding

TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007357 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 1986 to 2022
$4.8M
The Functional Role of the PXL Domain of SGK1 in Epithelial Sodium TransportK08DK073487 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PAO, ALAN C · 2006 to 2010
$599k
NIDDK NIH HHS K08 DK073487NIDDK NIH HHS K08-DK-073487NIDDK NIH HHS T32 DK007357NIDDK NIH HHS T32-DK07357-26A1
6 · The paper itself

Abstract

Gamma-Melanocyte Stimulating Hormone (Gamma-MSH) regulates sodium (Na(+)) balance and blood pressure through activation of the melanocortin receptor 3 (MC3-R). The mechanism of the natriuretic effect is proposed to involve binding of MC3-R either in the kidney to directly inhibit tubular Na(+) transport or in the brain to inhibit central neural pathways that control renal tubular Na(+) absorption. This study aimed to clarify the mechanism involved in the natriuretic effect of Gamma-MSH on MC3-R in kidney cells. In Ussing chamber studies, we observed no effects of Gamma-MSH on NaCl transport in the mouse inner medullary collecting duct cell line (mIMCD-K2). We also found that neither MC3-R protein nor mRNA was expressed in mouse kidney, suggesting that renal Gamma-MSH action may not be mediated through direct effects on tubular Na(+) transport but rather through effects on central neural pathways that innervate the kidney.

Indexed as

AnimalsBiological TransportBlotting, WesternCell LineCyclic AMPgamma-MSHImmunohistochemistryKidney Tubules, CollectingMiceMice, Inbred C57BLMice, KnockoutReceptor, Melanocortin, Type 3Reverse Transcriptase Polymerase Chain ReactionSignal TransductionSodiumCyclic AMPgamma-MSHReceptor, Melanocortin, Type 3Sodium

Identifiers

PMID21335042
PMCPMC3112371
OpenAlexW2024913813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.